Insmed Reaffirms Full-Yr 2026 Fincl Guidance of Rev in Range of $1.25B-$1.4B for BRINSUPRI >INSM

Dow Jones2026/10/05 11:05

By:Dow Jones

Insmed Reaffirms Full-Yr 2026 Fincl Guidance of Rev in Range of $1.25B-$1.4B for BRINSUPRI >INSM

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.